Crossmark

Bridging Therapeutics and Nanotechnology in Dry Eye Disease: A Review of Risk Factors, Drug Delivery Barriers, and Recent and Future Endeavors for Disease Management

Crossref DOI link: https://doi.org/10.1208/s12249-026-03442-2

Published Online: 2026-05-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Salama, Mayar https://orcid.org/0009-0005-7187-3161
Adel, Islam M. https://orcid.org/0000-0002-0347-0513
Tag, Randa https://orcid.org/0009-0006-6685-8984
Fares, Ahmed R. https://orcid.org/0009-0002-2964-8639
Funding

Funding for this research was provided by:

Cairo University
License Information

Text and Data Mining valid from 2026-05-12

Version of Record valid from 2026-05-12
More Information

Article History

Received: 10 February 2026

Accepted: 20 April 2026

First Online: 12 May 2026

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below